Left Ventricular Assist Devices in the Management of Heart Failure.

摘要: Mechanical circulatory support has emerged as an important therapy for advanced heart failure, with more than 18,000 continuous flow devices implanted worldwide to date. These significantly improve survival and quality of life should be considered in every patient end-stage failure reduced ejection fraction who no other life-limiting diseases. All candidates device implantation undergo a thorough evaluation order identify those could benefit from implantation. Long-term management ventricular assist patients is challenging requires knowledge the characteristic complications their unique clinical presentations.